ABBV · 10-Q · 2026Q3 · Full report

Gross Margin Drivers

AbbVie Inc. · 2026-11-03 · Importance 54 · Surprise 40

Gross margin was $13.119 billion for the three months and $36.602 billion for the nine months ended September 30, 2026, compared with $10.472 billion and $30.890 billion, respectively, in 2025. Gross margin as a percentage of net revenues increased in both periods, supported by higher revenue against lower fixed costs. Lower intangible-asset amortization contributed to the improvement, while the prior-year comparison also included $847 million of intangible-asset impairment charges in the September 2025 quarter.

Key facts

• Gross margin percentage increased in the three and nine months ended September 30, 2026, primarily because higher net revenues were compared with lower fixed costs, including lower intangible-asset amortization; the comparison also reflected $847 million of intangible-asset impairment charges in the three months ended September 30, 2025. source